1. Home
  2. FLUX vs LTRN Comparison

FLUX vs LTRN Comparison

Compare FLUX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

BUY

Current Price

$0.41

Market Cap

11.9M

Sector

Miscellaneous

ML Signal

BUY

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

BUY

Current Price

$0.64

Market Cap

10.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FLUX
LTRN
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
10.0M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FLUX
LTRN
Price
$0.41
$0.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.53
★ $17.50
AVG Volume (30 Days)
★ 503.9K
298.1K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
★ 18.65
EPS
★ N/A
N/A
Revenue
★ $9,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$85.96
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 126.25
N/A
52 Week Low
$0.40
$0.63
52 Week High
$7.55
$4.34

Technical Indicators

Market Signals
Indicator
FLUX
LTRN
Relative Strength Index (RSI) 36.77 19.78
Support Level $0.40 N/A
Resistance Level $0.55 $1.96
Average True Range (ATR) 0.05 0.10
MACD -0.00 0.02
Stochastic Oscillator 9.43 12.13

Price Performance

Historical Comparison
FLUX
LTRN

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: